$0.695
0.0124[1.82%]
At close: Apr 25
$0.695
0[0.00%]
After Hours: 8:57AM EDT
Aptevo Therapeutics
(NASDAQ:APVO)Aptevo Therapeutics Stock (NASDAQ:APVO), Quotes and News Summary
Aptevo Therapeutics Stock (NASDAQ: APVO) stock price, news, charts, stock research, profile.
| Open | $0.680 |
| Close | $0.680 |
| Volume / Avg. | 341.361K / 268.167K |
| Day Range | 0.670 - 0.705 |
| 52 Wk Range | 0.670 - 91.960 |
| Market Cap | $2.498M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 22 |
| Short Interest | 0.95% |
| Days to Cover | 1 |
Recent News
No news found
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Aptevo Therapeutics Inc
Sector
Health Care
Industry
Biotechnology
Aptevo Therapeutics Inc is a clinical-stage, research and development biotechnology company focused ...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Aptevo Therapeutics (APVO) stock?
You can purchase shares of Aptevo Therapeutics (NASDAQ: APVO) through any online brokerage.
Who are Aptevo Therapeutics's (APVO) competitors?
Other companies in Aptevo Therapeutics’s space includes: Dermata Therapeutics (NASDAQ:DRMA), NeuBase Therapeutics (NASDAQ:NBSE), Bone Biologics (NASDAQ:BBLG), Quoin Pharmaceuticals (NASDAQ:QNRX) and Qualigen Therapeutics (NASDAQ:QLGN).
What is the target price for Aptevo Therapeutics (APVO) stock?
The latest price target for Aptevo Therapeutics (NASDAQ: APVO) was reported by Piper Sandler on Friday, May 13, 2022. The analyst firm set a price target for 20.00 expecting APVO to rise to within 12 months (a possible 2777.70% upside). 0 analyst firms have reported ratings in the last year.
Current Stock Price for Aptevo Therapeutics (APVO)?
The stock price for Aptevo Therapeutics (NASDAQ: APVO) is $0.695 last updated Today at April 25, 2024 at 8:57 AM EDT.
Does Aptevo Therapeutics (APVO) pay a dividend?
There are no upcoming dividends for Aptevo Therapeutics.
When is Aptevo Therapeutics (NASDAQ:APVO) reporting earnings?
Aptevo Therapeutics’s Q1 earnings are confirmed for Thursday, May 9, 2024.
Is Aptevo Therapeutics (APVO) going to split?
There is no upcoming split for Aptevo Therapeutics.
What sector and industry does Aptevo Therapeutics (APVO) operate in?
Aptevo Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.